Massachusetts General Hospital: Crohn Disease trials

The registry lists 14 Crohn Disease studies with Massachusetts General Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 3 1No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Thermal Measurements of the Gut With a Colonoscope Compatible Thermal ProbeEnrolling by invitationNCT07352995Not applicable
• A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE CapsuleRecruitingNCT07219537Not applicable
• Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal VarianceRecruitingNCT07033208Not applicable
• Family Members at INcreased-risk for Developing Inflammatory Bowel DiseaseRecruitingNCT06655415
• Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.RecruitingNCT06252493
• Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and FeasibilityRecruitingNCT05332639Not applicable
• Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn DiseaseRecruitingNCT04508088
• Biomarkers to Predict and Monitor Response to InfliximabStatus unknownNCT04655729
• Feasibility Study to Assess a Trans-nasal Intestinal Potential Difference ProbeActive, not recruitingNCT04565821Not applicable
• Adjunctive Treatment With Vitamin D3 in Patients With Active IBDSuspendedNCT04225819Not applicable
• Inflammatory Bowel Disease Tracker (IBD Tracker)WithdrawnNCT03953794
• Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel DiseaseCompletedNCT03266484Not applicable
• Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative ColitisActive, not recruitingNCT02412553Not applicable
• Imuran (Azathioprine) Dose-Ranging Study in Crohn's DiseaseTerminatedNCT00098111Phase 3